284
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Exploring Dysregulated Ferroptosis-Related Genes in Septic Myocardial Injury Based on Human Heart Transcriptomes: Evidence and New Insights

, , , , , , , & show all
Pages 995-1015 | Received 07 Dec 2022, Accepted 25 Feb 2023, Published online: 09 Mar 2023
 

Abstract

Introduction

Sepsis is currently a common condition in emergency and intensive care units, and is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Cardiac dysfunction caused by septic myocardial injury (SMI) is associated with adverse prognosis and has significant economic and human costs. The pathophysiological mechanisms underlying SMI have long been a subject of interest. Recent studies have identified ferroptosis, a form of programmed cell death associated with iron accumulation and lipid peroxidation, as a pathological factor in the development of SMI. However, the current understanding of how ferroptosis functions and regulates in SMI remains limited, particularly in the absence of direct evidence from human heart.

Methods

We performed a sequential comprehensive bioinformatics analysis of human sepsis cardiac transcriptome data obtained through the GEO database. The lipopolysaccharide-induced mouse SMI model was used to validate the ferroptosis features and transcriptional expression of key genes.

Results

We identified widespread dysregulation of ferroptosis-related genes (FRGs) in SMI based on the human septic heart transcriptomes, deeply explored the underlying biological mechanisms and crosstalks, followed by the identification of key functional modules and hub genes through the construction of protein-protein interaction network. Eight key FRGs that regulate ferroptosis in SMI, including HIF1A, MAPK3, NOX4, PPARA, PTEN, RELA, STAT3 and TP53, were identified, as well as the ferroptosis features. All the key FRGs showed excellent diagnostic capability for SMI, part of them was associated with the prognosis of sepsis patients and the immune infiltration in the septic hearts, and potential ferroptosis-modulating drugs for SMI were predicted based on key FRGs.

Conclusion

This study provides human septic heart transcriptome-based evidence and brings new insights into the role of ferroptosis in SMI, which is significant for expanding the understanding of the pathobiological mechanisms of SMI and exploring promising diagnostic and therapeutic targets for SMI.

This article is part of the following collections:
Genetic and Non-Genetic Inflammation Networks in Major Human Diseases

Data Sharing Statement

Publicly available datasets were utilized in this study. The data used to support the results of this study are available from the online website mentioned above, and further inquiries can be directed to the corresponding author.

Ethics Statement

All animal experiments were approved by the Animal Experimentation Ethics Committee of the First Affiliated Hospital of Nanchang University (ethics number: CDYFY-IACUC-202209QR004). GEO database is a publicly accessible database, and includes patient data that have obtained ethical approval. There are no other required ethical statements.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work.

Additional information

Funding

This research was supported by the National Natural Science Foundation of China (No. 81960059), the Natural Science Foundation of Jiangxi, China (No. 20212BAB206021, No. 20224ACB206002, No. 20192BAB205004) and Jiangxi Province College students innovation and entrepreneurship Training Program (S202110403016).